HSP90AA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.167000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.462840E-01
Normal-vs-Stage2
3.238200E-01
Normal-vs-Stage3
8.021000E-01
Normal-vs-Stage4
1.622210E-01
Stage1-vs-Stage2
3.480000E-01
Stage1-vs-Stage3
2.940600E-01
Stage1-vs-Stage4
2.773000E-01
Stage2-vs-Stage3
3.423800E-01
Stage2-vs-Stage4
1.635190E-01
Stage3-vs-Stage4
1.400820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.205800E-01
Normal-vs-AfricanAmerican
3.828400E-01
Normal-vs-Asian
4.239400E-01
Caucasian-vs-AfricanAmerican
6.974800E-01
Caucasian-vs-Asian
4.924000E-01
AfricanAmerican-vs-Asian
8.919200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.102800E-01
Normal-vs-Female
2.676400E-01
Male-vs-Female
4.492200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.728000E-01
Normal-vs-Age(41-60Yrs)
2.881800E-01
Normal-vs-Age(61-80Yrs)
2.957400E-01
Normal-vs-Age(81-100Yrs)
1.499190E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.724400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.952000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.665400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.974400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.615600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.952600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.262800E-01
Normal-vs-Daily Drinker
4.740600E-01
Normal-vs-Weekly Drinker
4.080600E-01
Normal-vs-Occasional Drinker
8.190100E-02
Normal-vs-Social Drinker
1.889210E-01
Non Drinker-vs-Daily Drinker
5.375800E-01
Non Drinker-vs-Weekly Drinker
6.857600E-01
Non Drinker-vs-Occasional Drinker
1.262290E-02
Non Drinker-vs-Social Drinker
9.237400E-01
Daily Drinker-vs-Weekly Drinker
8.905400E-01
Daily Drinker-vs-Occasional Drinker
6.080900E-03
Daily Drinker-vs-Social Drinker
4.993600E-01
Weekly Drinker-vs-Occasional Drinker
2.109800E-02
Weekly Drinker-vs-Social Drinker
6.100600E-01
Occasional Drinker-vs-Social Drinker
2.765800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.688400E-01
Normal-vs-Grade 2
3.734400E-01
Normal-vs-Grade 3
1.562770E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.383200E-01
Grade 1-vs-Grade 3
3.857800E-01
Grade 1-vs-Grade 4
3.688400E-01
Grade 2-vs-Grade 3
9.054000E-01
Grade 2-vs-Grade 4
3.734400E-01
Grade 3-vs-Grade 4
1.562770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.221600E-01
Normal-vs-NonDiabetic
3.700400E-01
Diabetic-vs-NonDiabetic
4.986800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.398160E-01
Normal-vs-NoPancreatitis
3.535600E-01
Pancreatitis-vs-NoPancreatitis
1.068220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.775200E-01
Normal-vs-N1
3.236000E-01
N0-vs-N1
3.283200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.635200E-03
Normal-vs-TP53-NonMutant
3.537400E-01
TP53-Mutant-vs-TP53-NonMutant
4.900100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
